THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, is scheduled to present at the Cambria Capital Investor Meeting in Salt Lake City on March 27, 2008 at 4:00 p.m. MDT.
